Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

Kosuke OkazakiDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan

Manabu MakinodanDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, JapanCorrespondence[email protected]

Kazuhiko YamamuroDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan

Tomoyo TakataDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan

Toshifumi KishimotoDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan

Pages 3195-3198 | Published online: 14 Dec 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

RoehrBHalf a million Americans use methamphetamine every weekBMJ2005331476
PubMed Web of Science ®Google Scholar
NaruseNMethamphetamine, cannabisNihon Rinsho2015731481148626394507
PubMedGoogle Scholar
KishimotoMUjikeHMotohashiYThe dysbindin gene (DTNBP1) is associated with methamphetamine psychosisBiol Psychiatry20086319119617555717
PubMed Web of Science ®Google Scholar
MatsuzawaDHashimotoKMiyatakeRIdentification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosisAm J Psychiatry20071641105111417606663
PubMed Web of Science ®Google Scholar
MahoneyJJ3rdKalechsteinADDe La GarzaR2ndNewtonTFPresence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participantsAm J Addict200817839818393050
PubMed Web of Science ®Google Scholar
BatkiSLHarrisDSQuantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesiaAm J Addict20041346147015764424
PubMed Web of Science ®Google Scholar
MoralesAMLeeBHellemannGO’NeillJLondonEDGray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamineDrug Alcohol Depend201212523023822445480
PubMed Web of Science ®Google Scholar
LondonEDKohnoMMoralesAMBallardMEChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimagingBrain Res2015162817418525451127
PubMed Web of Science ®Google Scholar
ChinKMChannickRNRubinLJIs methamphetamine use associated with idiopathic pulmonary arterial hypertension?Chest20061316571663
Web of Science ®Google Scholar
IshigamiATokunagaIGotohdaTKuboSImmunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusersLeg Med (Tokyo)20035424812935649
PubMedGoogle Scholar
SatoMNumachiYHamamuraTRelapse of paranoid psychotic state in methamphetamine model of schizophreniaSchizophr Bull1992181151221553491
PubMed Web of Science ®Google Scholar
SlayterEMUnderstanding and overcoming barriers to substance abuse treatment access for people with mental retardationJ Soc Work Disabil Rehabil20087638019042302
PubMedGoogle Scholar
VanDErNagelJKiewikMBuitellarJDeJongCStaff perspectives of substance use and misuse among adults with intellectual disabilities enrolled in Dutch disability servicesJ Policy Pract Intellect Disabil20118143149
Web of Science ®Google Scholar
MatsonJLMahanSAntipsychotic drug side effects for persons with intellectual disabilityRes Dev Disabil2010311570157620580203
PubMed Web of Science ®Google Scholar
PolednakAPPost-mortem neuropathology in a mentally retarded populationLancet1977149249365603
PubMed Web of Science ®Google Scholar
MurasakiMNishikawaHIshibashiTDopamine-serotonin antagonist: receptor binding profile of a novel antipsychotic blonanserinJpn J Clin Psychopharmacol200811845854
Google Scholar
TenjinTMiyamotoSNinomiyaYProfile of blonanserin for the treatment of schizophreniaNeuropsychiatr Dis Treat2013958759423766647
PubMed Web of Science ®Google Scholar
HidaHMouriAMoriKBlonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D3-5-HT2A and D1-NMDA receptors in the mPFCNeuropsychopharmacology20154060161325120077
PubMed Web of Science ®Google Scholar
GarciaERobertMPerisFNakamuraHSatoNTerazawaYThe efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre studyCNS Drugs20092361562519552488
PubMed Web of Science ®Google Scholar
DeeksEDKeatingGMBlonanserin: a review of its use in the management of schizophreniaCNS Drugs201024658420030420
PubMed Web of Science ®Google Scholar
KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
PubMed Web of Science ®Google Scholar
SawamuraJMorishitaSIshigookaJIs there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysisBMC Psychiatry20101010521134296
PubMed Web of Science ®Google Scholar
MisraLKofoedLRisperidone treatment of methamphetamine psychosisAm J Psychiatry19971541170
PubMed Web of Science ®Google Scholar
ShoptawSJKaoULingWWTreatment for amphetamine psychosisCochrane Database Syst Rev2008Cd00302618843639
PubMed Web of Science ®Google Scholar
VerachaiVRuknganWChawanakrasaesinKTreatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapinePsychopharmacology (Berl)20142313099310824535654
PubMed Web of Science ®Google Scholar
SulaimanAHGillJSSaidMAZainalNZHusseinHMGuanNCA randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosisInt J Psychiatry Clin Pract20131713113822486597
PubMed Web of Science ®Google Scholar
LeelahanajTKongsakonRNetrakomPA 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosisJ Med Assoc Thai200588Suppl 3S43S52
Google Scholar
ParyRJDiscontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illnessAm J Ment Retard19951002072128527116
PubMedGoogle Scholar
StahlSMStahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Application3rd edCambridgeCambrige University Press2008
Google Scholar
NakajimaSGerretsenPTakeuchiHThe potential role of dopamine D3 receptor neurotransmission in cognitionEur Neuropsychopharmacol20132379981323791072
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date